NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Capital Reinvestment Ratio
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Capital Reinvestment Ratio of 0.00x as of December 2022, meaning it reinvests 0% of its operating cash flow ($29.19 Million) in capital expenditures ($109.43K). See NAMS equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NewAmsterdam Pharma Company N.V. Ordinary Shares Capital Reinvestment Ratio (2022–2022)
This chart tracks NewAmsterdam Pharma Company N.V. Ordinary Shares's Capital Reinvestment Ratio across 1 annual periods. Check NAMS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)
Year-by-year Capital Reinvestment Ratio for NewAmsterdam Pharma Company N.V. Ordinary Shares from 2022 to 2022. For live market cap and broader valuation context, see NewAmsterdam Pharma Company N.V. Ordinar (NAMS) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.02x | $10.66 Million | $221.00K | — |